CONTEXT: Obesity is associated with lower serum concentrations of 25-hydroxyvitamin D (25OHD) and higher intact PTH. The threshold of 25OHD needed to maximally suppress intact PTH has been suggested as a marker of optimal vitamin D status. OBJECTIVE: In this study, we hypothesized that whereas the obese have a higher serum PTH and lower 25OHD, suppression of serum PTH by 25OHD would be independent of body weight. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective analysis on 383 women (ages 24-75 y) with a wide range of body weights (43-185 kg) who were stabilized to 1-1.2 g calcium/d for 1 month before blood draw. Body composition, serum PTH, 25OHD, calcium, and creatinine were measured. Locally weighted regression and smoothing scatterplots were used to depict the association between serum PTH and 25OHD. A nonlinear exponential model determined the point for near maximal suppression of PTH by 25OHD. RESULTS: The point for near maximal suppression of PTH by 25OHD for all women (body mass index, 31.4 ± 7.7 kg/m²) occurred at a 25OHD concentration of 21.7 ng/mL (95% confidence interval, 28-48 ng/mL). No point of maximal suppression was found for nonobese women, yet in the obese women (n = 207; body mass index, >30 kg/m²) suppression of PTH occurred at a 25OHD concentration of 11.1 ng/mL (95% confidence interval, 4.7-17.5 ng/mL). CONCLUSIONS: These results suggest that if PTH is suppressed at a lower serum 25OHD in the obese compared to the entire population, the lower average 25OHD concentrations in the obese may not have the same physiological significance as in the general population.
CONTEXT: Obesity is associated with lower serum concentrations of 25-hydroxyvitamin D (25OHD) and higher intact PTH. The threshold of 25OHD needed to maximally suppress intact PTH has been suggested as a marker of optimal vitamin D status. OBJECTIVE: In this study, we hypothesized that whereas the obese have a higher serum PTH and lower 25OHD, suppression of serum PTH by 25OHD would be independent of body weight. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective analysis on 383 women (ages 24-75 y) with a wide range of body weights (43-185 kg) who were stabilized to 1-1.2 g calcium/d for 1 month before blood draw. Body composition, serum PTH, 25OHD, calcium, and creatinine were measured. Locally weighted regression and smoothing scatterplots were used to depict the association between serum PTH and 25OHD. A nonlinear exponential model determined the point for near maximal suppression of PTH by 25OHD. RESULTS: The point for near maximal suppression of PTH by 25OHD for all women (body mass index, 31.4 ± 7.7 kg/m²) occurred at a 25OHD concentration of 21.7 ng/mL (95% confidence interval, 28-48 ng/mL). No point of maximal suppression was found for nonobese women, yet in the obesewomen (n = 207; body mass index, >30 kg/m²) suppression of PTH occurred at a 25OHD concentration of 11.1 ng/mL (95% confidence interval, 4.7-17.5 ng/mL). CONCLUSIONS: These results suggest that if PTH is suppressed at a lower serum 25OHD in the obese compared to the entire population, the lower average 25OHD concentrations in the obese may not have the same physiological significance as in the general population.
Authors: Marieke B Snijder; Rob M van Dam; Marjolein Visser; Dorly J H Deeg; Jacqueline M Dekker; Lex M Bouter; Jaap C Seidell; Paul Lips Journal: J Clin Endocrinol Metab Date: 2005-04-26 Impact factor: 5.958
Authors: Miriam Blum; Gregory Dolnikowski; Elias Seyoum; Susan S Harris; Sarah L Booth; James Peterson; Edward Saltzman; Bess Dawson-Hughes Journal: Endocrine Date: 2008-03-13 Impact factor: 3.633
Authors: H Jiang; D-H Xiong; Y-F Guo; H Shen; P Xiao; F Yang; Y Chen; F Zhang; R R Recker; H-W Deng Journal: Int J Obes (Lond) Date: 2007-03-06 Impact factor: 5.095
Authors: Yu-Kwang Donovan Tay; Randy Yeh; Jennifer H Kuo; Catherine McManus; James A Lee; John P Bilezikian Journal: Endocrine Date: 2018-02-05 Impact factor: 3.633
Authors: JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring Journal: N Engl J Med Date: 2018-11-10 Impact factor: 91.245
Authors: Daniela Alves Salazar; Maria João Silva Ferreira; João Sérgio Neves; Jorge Manuel Pires Pedro; Vanessa Alexandra Guerreiro; Sara E Silva Viana; Fernando Mendonça; Maria Manuel Silva; Sandra Patrícia Belo; Ana Varela Sande; Paula Freitas; David Maurício Carvalho Journal: Obes Surg Date: 2020-04 Impact factor: 4.129
Authors: Silvia Migliaccio; Andrea Di Nisio; Silvia Magno; Fiammetta Romano; Luigi Barrea; Anna Maria Colao; Giovanna Muscogiuri; Silvia Savastano Journal: Int J Obes (Lond) Date: 2022-01-14 Impact factor: 5.551
Authors: Jenifer M Brown; Jonathan S Williams; James M Luther; Rajesh Garg; Amanda E Garza; Luminita H Pojoga; Daniel T Ruan; Gordon H Williams; Gail K Adler; Anand Vaidya Journal: Hypertension Date: 2013-11-04 Impact factor: 10.190
Authors: Joseph Lunyera; Clemontina A Davenport; Jane Pendergast; Solomon K Musani; Nrupen A Bhavsar; Mario Sims; Stanford Mwasongwe; Myles Wolf; Clarissa J Diamantidis; L Ebony Boulware; Julia J Scialla Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Michelle Shardell; Anne R Cappola; Jack M Guralnik; Gregory E Hicks; Stephen B Kritchevsky; Eleanor M Simonsick; Luigi Ferrucci; Richard D Semba; Nancy Chiles Shaffer; Tamara Harris; Gudny Eiriksdottir; Vilmundur Gudnason; Mary Frances Cotch; Eric Orwoll; Kristine E Ensrud; Peggy M Cawthon Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045